These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 15322172)

  • 1. CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells.
    Makita S; Kanai T; Oshima S; Uraushihara K; Totsuka T; Sawada T; Nakamura T; Koganei K; Fukushima T; Watanabe M
    J Immunol; 2004 Sep; 173(5):3119-30. PubMed ID: 15322172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An essential role for Scurfin in CD4+CD25+ T regulatory cells.
    Khattri R; Cox T; Yasayko SA; Ramsdell F
    Nat Immunol; 2003 Apr; 4(4):337-42. PubMed ID: 12612581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis.
    Yu QT; Saruta M; Avanesyan A; Fleshner PR; Banham AH; Papadakis KA
    Inflamm Bowel Dis; 2007 Feb; 13(2):191-9. PubMed ID: 17206665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of murine inflammatory bowel disease by CD25+ and CD25- CD4+ glucocorticoid-induced TNF receptor family-related gene+ regulatory T cells.
    Uraushihara K; Kanai T; Ko K; Totsuka T; Makita S; Iiyama R; Nakamura T; Watanabe M
    J Immunol; 2003 Jul; 171(2):708-16. PubMed ID: 12847237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamina Propria CD4+LAP+ Regulatory T Cells Are Increased in Active Ulcerative Colitis but Show Increased IL-17 Expression and Reduced Suppressor Activity.
    D'Ambrosio A; Cossu A; Amendola A; Zandri A; Butera A; Sanchez M; Biffoni M; Pronio A; Montesani C; Kohn A; Pica R; Boirivant M
    J Crohns Colitis; 2016 Mar; 10(3):346-53. PubMed ID: 26589955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease.
    Kelsen J; Agnholt J; Hoffmann HJ; Rømer JL; Hvas CL; Dahlerup JF
    Clin Exp Immunol; 2005 Sep; 141(3):549-57. PubMed ID: 16045746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro.
    Yates J; Rovis F; Mitchell P; Afzali B; Tsang J; Garin M; Lechler RI; Lombardi G; Garden OA
    Int Immunol; 2007 Jun; 19(6):785-99. PubMed ID: 17545278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo.
    Taylor MD; LeGoff L; Harris A; Malone E; Allen JE; Maizels RM
    J Immunol; 2005 Apr; 174(8):4924-33. PubMed ID: 15814720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death.
    Chen X; Murakami T; Oppenheim JJ; Howard OMZ
    Eur J Immunol; 2004 Mar; 34(3):859-869. PubMed ID: 14991616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells.
    Nishimura E; Sakihama T; Setoguchi R; Tanaka K; Sakaguchi S
    Int Immunol; 2004 Aug; 16(8):1189-201. PubMed ID: 15237110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis.
    de Kleer IM; Wedderburn LR; Taams LS; Patel A; Varsani H; Klein M; de Jager W; Pugayung G; Giannoni F; Rijkers G; Albani S; Kuis W; Prakken B
    J Immunol; 2004 May; 172(10):6435-43. PubMed ID: 15128835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal lamina propria retaining CD4+CD25+ regulatory T cells is a suppressive site of intestinal inflammation.
    Makita S; Kanai T; Nemoto Y; Totsuka T; Okamoto R; Tsuchiya K; Yamamoto M; Kiyono H; Watanabe M
    J Immunol; 2007 Apr; 178(8):4937-46. PubMed ID: 17404275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
    Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H
    Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
    Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
    Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of immune homeostasis by naturally arising regulatory CD4+ T cells.
    Gavin M; Rudensky A
    Curr Opin Immunol; 2003 Dec; 15(6):690-6. PubMed ID: 14630204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
    Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
    J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.
    Allan SE; Crome SQ; Crellin NK; Passerini L; Steiner TS; Bacchetta R; Roncarolo MG; Levings MK
    Int Immunol; 2007 Apr; 19(4):345-54. PubMed ID: 17329235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal lymphoid aggregates in ulcerative colitis colon: a site for regulatory T cell action.
    Sitohy B; Hammarström S; Danielsson A; Hammarström ML
    Clin Exp Immunol; 2008 Feb; 151(2):326-33. PubMed ID: 18190460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+CD25+ regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype.
    Guo Z; Jang MH; Otani K; Bai Z; Umemoto E; Matsumoto M; Nishiyama M; Yamasaki M; Ueha S; Matsushima K; Hirata T; Miyasaka M
    Int Immunol; 2008 Mar; 20(3):307-15. PubMed ID: 18184698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunosuppressive drug FK778 induces regulatory activity in stimulated human CD4+ CD25- T cells.
    Kreijveld E; Koenen HJ; Hilbrands LB; van Hooff HJ; Joosten I
    Blood; 2007 Jan; 109(1):244-52. PubMed ID: 16902146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.